Eye implant could replace daily drops for glaucoma patients

NCT ID NCT04060758

Completed Disease control Sponsor: PolyActiva Pty Ltd Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 21 times

Summary

This early-stage study tested a tiny implant placed inside the eye that slowly releases medication to lower eye pressure in people with mild-to-moderate open-angle glaucoma. The goal was to find a safe and effective dose that reduces pressure by more than 20% with few side effects. 37 adults who already use eye drops took part. The implant is designed to offer a longer-lasting alternative to daily drops, but ongoing treatment is still needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bendigo Eye Clinic

Bendigo, Victoria, 3550, Australia
Capital Eye Specialists

Te Aro, 6011, New Zealand
Centre for Eye Research Australia

East Melbourne, Victoria, 3002, Australia
Essendon Eye Clinic

Essendon, Victoria, 3040, Australia
Eye Surgery Associates

Vermont South, Victoria, 3133, Australia
Eyes First

Springvale, Victoria, 3171, Australia
Goodwood Eye Centre

Millswood, South Australia, 5034, Australia
Melbourne Eye Specialists

Fitzroy, Victoria, 3065, Australia
PersonalEYES

Castle Hill, New South Wales, 2150, Australia

Conditions

Explore the condition pages connected to this study.

OPEN-ANGLE GLAUCOMA